DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
Clinical trial NCT03466320 · COMPLETED
Trial details
- NCT number
- NCT03466320
- Sponsor
- Celyad Oncology SA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2021-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.